HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 213 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,929,927 | -6.9% | 1,035,396 | 0.0% | 9.62% | -27.0% |
| Q2 2023 | $36,435,585 | +7.8% | 1,035,396 | 0.0% | 13.19% | -29.6% |
| Q1 2023 | $33,805,679 | -40.7% | 1,035,396 | 0.0% | 18.74% | +5.9% |
| Q4 2022 | $57,050,320 | +14.4% | 1,035,396 | -8.0% | 17.69% | +53.3% |
| Q3 2022 | $49,856,000 | -29.4% | 1,125,673 | -22.3% | 11.54% | -42.7% |
| Q2 2022 | $70,654,000 | -6.0% | 1,448,720 | -6.2% | 20.12% | +20.8% |
| Q1 2022 | $75,139,000 | -35.7% | 1,544,484 | -43.6% | 16.66% | -20.9% |
| Q4 2021 | $116,851,000 | -0.5% | 2,740,411 | -10.5% | 21.05% | +80.0% |
| Q3 2021 | $117,412,000 | +18.7% | 3,063,194 | -12.6% | 11.70% | +0.2% |
| Q2 2021 | $98,936,000 | -14.6% | 3,504,624 | 0.0% | 11.68% | +6.1% |
| Q1 2021 | $115,793,000 | -8.6% | 3,504,624 | 0.0% | 11.00% | -1.6% |
| Q4 2020 | $126,692,000 | +6.6% | 3,504,624 | 0.0% | 11.18% | -38.1% |
| Q3 2020 | $118,807,000 | – | 3,504,624 | – | 18.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $394,762,581 | 98.29% |
| venBio Partners LLC | 1,035,396 | $36,435,585 | 13.19% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,973,321 | 8.29% |
| Vivo Capital, LLC | 2,606,247 | $91,713,832 | 6.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $20,070,190 | 6.11% |
| Altium Capital Management LP | 149,889 | $5,274,594 | 3.99% |
| AlphaCentric Advisors LLC | 118,000 | $4,152,420 | 2.30% |
| ASHFORD CAPITAL MANAGEMENT INC | 449,038 | $15,801,647 | 2.21% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 636,240 | $22,389,286 | 2.05% |
| TANG CAPITAL MANAGEMENT LLC | 271,200 | $9,543,528 | 1.40% |